Shares of microcap Orexigen Therapeutics (OREX) are up 73% premarket after the firm announces a...

|About: Orexigen Therapeutics, Inc. (OREX)|By:, SA News Editor

Shares of microcap Orexigen Therapeutics (OREX) are up 73% premarket after the firm announces a meeting with the FDA led to a "clear and feasible" path for its Contrave drug to meet approval to treat obesity.